19155002

Bhattacharya SM

2009

Polycystic ovary syndrome and abnormalities in glucose tolerance.

19155004

Haydardedeoglu B

2009

Metabolic and endocrine effects of metformin and metformin plus cyclic medroxyprogesterone acetate in women with polycystic ovary syndrome.

19158047

Cheang KI

2008

Risk of cardiovascular events in mothers of women with polycystic ovary syndrome.

19158052

Joy TR

2008

Prevalence of reproductive abnormalities among women with familial partial lipodystrophy.

19158194

Aigner E

2009

Retinol-binding protein 4 in polycystic ovary syndrome--association with steroid hormones and response to pioglitazone treatment.

19158405

Manner?s L

2009

Acupuncture and exercise restore adipose tissue expression of sympathetic markers and improve ovarian morphology in rats with dihydrotestosterone-induced PCOS.

19160291

Siristatidis CS

2009

In vitro maturation in sub fertile women with polycystic ovarian syndrome undergoing assisted reproduction.

19161048

Stone JA

2009

Delivery of a full-term pregnancy after TCM treatment in a previously infertile patient diagnosed with polycystic ovary syndrome.

19163783

Deng Y

2008

Automated detection of Polycystic Ovary Syndrome from ultrasound images.

19168874

Hudecova M

2009

Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve.

19169049

Diamanti-Kandarakis E

2008

Low free plasma levels of retinol-binding protein 4 in insulin-resistant subjects with polycystic ovary syndrome.

19169057

Trakakis E

2008

Hemodynamic alterations and wall properties in large arteries of young, normotensive, and non-obese women with polycystic ovary syndrome.

19169352

Allemand MC

2009

Effect of testosterone on insulin stimulated IRS1 Ser phosphorylation in primary rat myotubes--a potential model for PCOS-related insulin resistance.

19170716

Glintborg D

2009

Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment.

19171332

Nafiye Y

2010

The effect of serum and intrafollicular insulin resistance parameters and homocysteine levels of nonobese, nonhyperandrogenemic polycystic ovary syndrome patients on in vitro fertilization outcome.

19171337

Markou A

2010

Hepatic steatosis in young lean insulin resistant women with polycystic ovary syndrome.

19172534

Van Nieuwerburgh F

2008

Shorter CAG repeats in the androgen receptor gene may enhance hyperandrogenicity in polycystic ovary syndrome.

19172699

Vanky E

2008

Haemoglobin, C-reactive protein and androgen levels in uncomplicated and complicated pregnancies of women with polycystic ovary syndrome.

19174109

Franco Hidalgo S

2009

[Toxic hepatitis associated with the use of medroxyprogesterone].

19175047

Ska?ba P

2008

[Progress in gynecological endocrinology].

19178532

Barba M

2009

The effects of metformin on endogenous androgens and SHBG in women: a systematic review and meta-analysis.

19179017

Kdous M

2009

[Oocyte and embryo quality and outcome of ICSI cycles in patients with polycystic ovary syndrome (PCOS) versus normo-ovulatory].

19180430

Kuhl H

2009

[Long-cycle treatment in oral contraception].

19185861

Kim JJ

2010

Estrogen receptor beta gene +1730 G/A polymorphism in women with polycystic ovary syndrome.

19187547

Giallauria F

2009

Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study.

19188739

Tsilchorozidou T

2009

Determinants of interleukin-6 and C-reactive protein vary in polycystic ovary syndrome, as do effects of short- and long-term metformin therapy.

19189992

Delgado-Rosas F

2009

Superficial ovarian cortex vascularization is inversely related to the follicle reserve in normal cycling ovaries and is increased in polycystic ovary syndrome.

19190317

Mattson-Dicecca AA

2009

Update: A 27-year-old woman with a diagnosis of polycystic ovary syndrome.

19191034

Wang B

2009

Lack of association between interleukin-1a gene (IL-1a) C (-889) T variant and polycystic ovary syndrome in Chinese women.

19192347

Fadini R

2009

Predictive factors in in-vitro maturation in unstimulated women with normal ovaries.

19193657

Li M

2009

Androgen receptor's destiny in mammalian oocytes: a new hypothesis.

19197132

Wang Y

2009

[Clinical significance and changes of serum visfatin, adiponectin and leptin levels in patients with polycystic ovarian syndrome].

19200978

Manzanares MA

2010

Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.

19200979

Ertunc D

2010

Gonadotropin-releasing hormone antagonist use in controlled ovarian stimulation and intrauterine insemination cycles in women with polycystic ovary syndrome.

19201404

Mala YM

2009

Three-dimensional power Doppler imaging in the diagnosis of polycystic ovary syndrome.

19204396

Schleussner E

2009

[Intrauterine programming of reproductive function--a valid concept?].

19204430

Ruan X

2009

Study on chronic low-grade inflammation and influential factors of polycystic ovary syndrome.

19204602

Brown AJ

2009

Effects of exercise on lipoprotein particles in women with polycystic ovary syndrome.

19205868

Moini A

2009

Familial associations between polycystic ovarian syndrome and common diseases.

19208775

Diamanti-Kandarakis E

2009

Anti-mullerian hormone is associated with advanced glycosylated end products in lean women with polycystic ovary syndrome.

19209619

Glueck CJ

2008

Insulin resistance, obesity, hypofibrinolysis, hyperandrogenism, and coronary heart disease risk factors in 25 pre-perimenarchal girls age < or =14 years, 13 with precocious puberty, 23 with a first-degree relative with polycystic ovary syndrome.

19211406

Jayaraman M

2009

Type 1 diabetes mellitus and polycystic ovary syndrome.

19211708

Mukherjee S

2009

Genetic variation in exon 17 of INSR is associated with insulin resistance and hyperandrogenemia among lean Indian women with polycystic ovary syndrome.

19212122

Diamanti-Kandarakis E

2009

Hyperreninemia characterizing women with polycystic ovary syndrome improves after metformin therapy.

19213337

Lian F

2008

[Combined therapy of Chinese medicine with in vitro fertilization and embryo transplantation for treatment of polycystic ovarian syndrome].

19213343

Li XH

2008

[Effects of cryptotanshinone in lowering androgens synthesis for the prenatally androgenized male rats].

19213486

Mourali M

2008

[Polycystic ovary syndrome with infertility].

19213514

Kdous M

2008

[Use of GnRh antagonist (Cetrorelix) in controlled ovarian hyperstimulation in women with polycystic ovary disease].

19214545

Roy KK

2009

Evaluation of unilateral versus bilateral ovarian drilling in clomiphene citrate resistant cases of polycystic ovarian syndrome.

19214546

Yildizhan R

2009

Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome.

19215335

Brzozowska MM

2009

An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.

19217093

Duleba AJ

2010

Predictors of urinary albumin excretion in women with polycystic ovary syndrome.

19218318

Balen A

2009

Defining polycystic ovary syndrome.

19218574

Kim JJ

2009

Phosphatidylinositol 3-kinase p85alpha regulatory subunit gene Met326Ile polymorphism in women with polycystic ovary syndrome.

19223290

Benson S

2009

Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany.

19223518

Sir-Petermann T

2009

Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome.

19228439

Trakakis E

2009

Congenital adrenal hyperplasia because of 21-hydroxylase deficiency. A genetic disorder of interest to obstetricians and gynecologists.

19230880

Mahmoudi T

2010

Calciotropic hormones, insulin resistance, and the polycystic ovary syndrome.

19231599

Heiman DL

2009

Amenorrhea.

19232596

Adali E

2009

Doppler analysis of uterine perfusion and ovarian stromal blood flow in polycystic ovary syndrome.

19240152

Hirshfeld-Cytron J

2009

Characterization of functionally typical and atypical types of polycystic ovary syndrome.

19240158

Mortensen M

2009

Asymptomatic volunteers with a polycystic ovary are a functionally distinct but heterogeneous population.

19241321

Hauth EA

2009

[Magnetic resonance imaging of the pelvis in patients with polycystic ovary syndrome].

19243758

Katsikis I

2009

Oligo-ovulation or anovulation and hyperandrogenemia contribute to the decreased serum adiponectin levels in normal-weight women with PCOS with obesity and insulin resistance.

19245356

Suzuki A

2009

Nonalcoholic fatty liver disease in women.

19246284

Li M

2009

[Association of the clinical characteristics and the IVF-ET outcome in infertile women with polycystic ovarian syndrome of different subtypes].

19246930

Gorkemli H

2009

Long-term effects of valproic acid on reproductive endocrine functions in Turkish women with epilepsy.

19246981

Kassi E

2008

The effects of insulin sensitizers on the cardiovascular risk factors in women with polycystic ovary syndrome.

19248002

Van Holsbeke C

2009

Hyperreactio luteinalis in a spontaneously conceived singleton pregnancy.

19249024

Son WY

2009

Comparison of survival rate of cleavage stage embryos produced from in vitro maturation cycles after slow freezing and after vitrification.

19249030

Huang A

2010

Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria.

19249763

Liu S

2010

Evaluation of the immature human oocytes from unstimulated cycles in polycystic ovary syndrome patients using a novel scoring system.

19253106

Oral B

2009

Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome.

19255602

Tasali E

2008

Polycystic Ovary Syndrome and Obstructive Sleep Apnea.

19261215

Fraser HM

2009

SRB Reproduction, Fertility and Development Award Lecture 2008. Regulation and manipulation of angiogenesis in the ovary and endometrium.

19261276

Mashiach R

2010

Follicular fluid levels of anti-Mullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome.

19261277

Yildiz BO

2010

Increased circulating soluble P-selectin in polycystic ovary syndrome.

19261392

Sahin M

2009

Possible effects of androgens on Islet Cell Functions.

19261627

Toulis KA

2009

Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis.

19264556

Papaioannou S

2010

Anovulation with or without PCO, hyperandrogenaemia and hyperinsulinaemia as promoters of endometrial and breast cancer.

19264868

Dissen GA

2009

Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans.

19268210

Brailly-Tabard S

2008

[Menometrorrhagia: to whom, why, on which criteria to propose a hormonal exploration?].

19268211

Bazot M

2008

[Diagnostic imaging of menometrorrhagia].

19268929

Romualdi D

2010

Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial.

19273509

Shumak SL

2009

Even lean women with PCOS are insulin resistant.

19273511

Zermansky AG

2009

Polycystic ovary syndrome. The right to a diagnosis?

19275679

Ling S

2009

Cardiovascular physiology of androgens and androgen testosterone therapy in postmenopausal women.

19279033

Homburg R

2009

Androgen circle of polycystic ovary syndrome.

19279045

Moran L

2009

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.

19294645

Penninx JP

2009

Management of pregnancy in a carrier of the Donohue mutation.

19296936

Hefler-Frischmuth K

2010

Serologic markers of autoimmunity in women with polycystic ovary syndrome.

19298279

Abdel Fattah NS

2009

Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism?

19298731

Orvieto R

2009

Ovarian stimulation in polycystic ovary syndrome patients: the role of body mass index.

19299314

Palaniappan M

2009

Regulation of sterol regulatory element-binding transcription factor 1a by human chorionic gonadotropin and insulin in cultured rat theca-interstitial cells.

19300392

Hao CF

2009

Evaluation of association between the CYP11alpha promoter pentannucleotide (TTTTA)n polymorphism and polycystic ovarian syndrome among Han Chinese women.

19301026

Shirazian N

2009

Screening for gestational diabetes: usefulness of clinical risk factors.

19303967

Makimura H

2009

Retinol-binding protein levels are increased in association with gonadotropin levels in healthy women.

19303981

Livadas S

2009

Elevated coagulation and inflammatory markers in adolescents with a history of premature adrenarche.

19306135

Kumbak B

2009

Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization.

19308750

Ku??u NK

2009

Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome.